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Rapidly evolving viruses and other pathogens can have an immense impact on human evolution as
natural selection acts to increase the prevalence of genetic variants providing resistance to disease.
With the emergence of large datasets of human genetic variation, we can search for signatures of natu-
ral selection in the human genome driven by such disease-causing microorganisms. Based on this
approach, we have previously hypothesized that Lassa virus (LASV) may have been a driver of natural
selection in West African populations where Lassa haemorrhagic fever is endemic. In this study, we
provide further evidence for this notion. By applying tests for selection to genome-wide data from
the International Haplotype Map Consortium and the 1000 Genomes Consortium, we demonstrate
evidence for positive selection in LARGE and interleukin 21 (IL21), two genes implicated in LASV
infectivity and immunity. We further localized the signals of selection, using the recently developed
composite of multiple signals method, to introns and putative regulatory regions of those genes.
Our results suggest that natural selection may have targeted variants giving rise to alternative splicing
or differential gene expression of LARGE and IL21. Overall, our study supports the hypothesis that
selective pressures imposed by LASV may have led to the emergence of particular alleles conferring
resistance to Lassa fever, and opens up new avenues of research pursuit.
Keywords: Lassa fever; natural selection; positive selection; genome-wide scans;
LARGE; interleukin 21
1. INTRODUCTION
Disease-causing pathogens are among the most intri-
guing forces shaping human evolution, as they have a
tremendous impact on our genome and themselves
evolve over time. They are also among the best-
understood drivers of human evolution. In 1949,
Haldane [1] made the observation that sickle cell anae-
mia, thalassaemias and other blood cell disorders were
prominent in malaria-endemic regions of the world. He
hypothesized that these disorders had become common
in these regions through natural selection acting to
increasetheprevalenceoftraitsthatprotectfrommalaria.
‘TheHaldanehypothesis’wasconﬁrmedin1954byA.C.
Allison. Allison [2] demonstrated that the geographical
distribution of the sickle cell mutation (Glu6Val) in
haemoglobin B (HbS)c o r r e l a t e dw i t hm a l a r i ae n d e m i -
city, was present only in Africa, and individuals carrying
the sickle cell trait were resistant to malaria.
The conﬁrmation of Haldane’s malaria hypothesis
provided an elegant ﬁrst example of human adaptation,
whichgavestrongsupportforDarwin’stheoryofnatural
selection proposed a century earlier. It also provided a
clear demonstration of how natural selection can point
us to biological mechanisms for resistance to infectious
disease. As traits conferring resistance had arisen and
spread in malaria endemic regions, the process gener-
ated striking and tractable differences between human
populations—a signature of natural selection. Through
natural selection, genetic variants that confer resistance
to infectious diseases can spread through human popu-
lations over time, leaving such distinctive patterns in the
human genome [3].
With emerging datasets of genomic variation in
humans and pathogens, we can exploit the genetic
signatures of natural selection towards identifying
mechanisms of defence to many diseases [4]. The
explosion in genotyping and high-throughput sequen-
cing has made possible surveys of human genetic
variation from multiple populations in large-scale col-
laborations such as the International Haplotype Map
(HapMap) Consortium [5] and the 1000 Genomes
(1000 G) Consortium [6]. The second phase of the
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surveys of natural selection in the human genome, and
examined 3.1 million single-nucleotide polymorphisms
(SNPs) from 270 individuals from four populations:
Yorubans from Nigeria in West Africa (YRI), Han
Chinese from Beijing (CHB), Japanese from Tokyo
(JPT) and European-ancestry individuals from Utah
(CEU). The recently completed ﬁrst phase of the
1000G has enabled us now to look at genetic variation
at every nucleotide in the human genome. For its initial
release, 1000G has provided approximately four-time
coverageofwholegenomesequencingfrom179individ-
uals from the same four populations studied in the
HapMap. The 1000G dataset is currently expanding
with more populations and individuals, but further
quality control efforts need to be performed before it
can be solely relied upon. Using these genotyping and
sequencing datasets, several computational tools have
been developed and applied to identify genes and
regions in the human genome under positive selection
(box 1)[ 3,7].
By examining evidence for natural selection in the
HapMap data for YRI, we identiﬁed that one of
the strongest signalsof selectionwas at a 300kb genomic
region entirely within the gene LARGE [10]. The
LARGE protein is a glycosylase that post-translationally
modiﬁes a-dystroglycan (a-DG), the cellular receptor
for Lassa virus (LASV), and the modiﬁcation has been
shown to be critical for virus binding [12]. These results
led us to the hypothesis that LASV protective alleles may
haveemergedandspreadthroughWestAfrica,conferring
resistance to severe disease from LASV infection.
Lassa haemorrhagic fever (LF) is a severe illness
caused by LASV. It is endemic in West Africa and esti-
mated to infect hundreds of thousands of individuals
eachyearwiththousandsofdeaths[13].Thesenumbers
are probably underestimates, as most patients are never
seen in hospital or are misdiagnosed with other febrile
diseases such as malaria [14]. Past serological surveys
point to its widespread impact, showing 21 per cent of
Nigerians(approx.30millionpeople)havehadprevious
exposure to the virus [13], and exposure in parts of
Sierra Leone and Guinea is above 50 per cent [13].
Therefore,LFisarguablyoneofthe most neglectedtro-
pical diseases, given the numberof people that it affects,
itspotentialharm,andtheunaddressedneedforabetter
understanding of its complex biology.
In this study, we carried out a thorough examination
of evidence for selection at genes biologically linked to
LF, in order to pursue the hypothesis that these genes
might be adaptations driving LF resistance in endemic
areas. We conﬁrmed the signal of selection at LARGE
[10]andidentiﬁedevidenceofselectioninWestAfricans
for IL21—another gene biologically linked to LF. Using
a recently developed computational approach, the com-
posite of multiple signals (CMS), we narrowed the
signals to within the ﬁrst two introns of LARGE and to
a cluster around IL21 also containing IL2 and ADAD1.
We found that using either the HapMap II or 1000G
datasets gave similar results. In both cases, the top 10
high-scoring SNPs occur outside open reading frames
(ORFs), suggesting that particular variants may have
been selected based on their ability to affect gene
regulation of LARGE and IL21. Using comparative
Box 1. Signatures of natural selection detectable in genomic datasets. Most methods to detect natural selection fall into
six categories of broadly deﬁned signatures of positive selection.
— Function altering mutations (millions of years). When a protein is under strong selection, the number of non-synon-
ymous (DN) to synonymous (DS) changes in its open reading frame may change dramatically. An excess of DN
suggests that positive selection has worked on the protein, whereas an excess of DS suggests negative or purifying
selection. Similarly, tests have been developed to identify an excess of potential function altering mutations in
non-coding regions [8].
— Reduction in genetic diversity around selected allele (less than 250 000 years). As a variant under positive selection rises in
frequency, ‘hitch-hiking’ nearby alleles increase in frequency as well. Such a ‘selective sweep’ leads to an overall
decrease in diversity in the selected region with a simultaneous increase in the number of rare alleles as new SNPs
are ‘born’ near the positively selected allele.
— Increase in the frequency of derived alleles (less than 80000 years). When new alleles arise, they have a lower frequency
than already present (ancestral) alleles. However, during a selective sweep, the selected allele as well as nearby neutral
derived alleles will rapidly rise in frequency. A region with a high proportion of many derived alleles is therefore good
evidence for positive selection having occurred in that part of the genome.
— Increase in population differentiation (less than 75 000 years) A particular allele may be beneﬁcial in one population but
not in another. In such a case, there will be a large difference between the frequency of the allele in one population
versus the other.
— Long-range haplotypes (less than 30 000 years). Recombination during meiosis continuously breaks down
associations between alleles on the same chromosomes. During a selective sweep, however, the selected variant
rises quickly in frequency, leaving links with nearby alleles on the ancestral chromosome intact. This increase in
‘linkage disequilibrium’ leads to chromosomal regions where the haplotype is unusually long. This signature
of positive selection can be measured using various haplotype-based tests, such as LRH [4], iHS [9] and XP-
EHH [10].
— Composite of multiple signals (CMS)( ??? years). While most of these tests have been successful in identifying regions
under selection, in many cases, the individual genes or variants under selection remain obscured due to a lack of
spatial resolution. Because strongly selected variants should contain many of the above ﬁve mentioned signatures,
we have recently developed a ‘CMS’ method to improve spatial resolution up to 100-fold [11] allowing us to identify
and localize speciﬁc variants under positive selection.
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high proportion of SNPs in its ORF in humans but not
in other species. It therefore appears that this gene,
which we found to be under strict purifying selection
in mammals, may experience diversifying selection in
humans. Overall, this provides evidence for the hypoth-
esis that selection pressures caused by LASV may have
led to positive selection of particular alleles conferring
resistance to LASV infection or disease.
2. LASSA FEVER
LF was ﬁrst described in the town of Lassa in Northern
Nigeria in 1969 [15]. It is endemic in West Africa with
high disease prevalence in the Mano River Union
countries, Sierra Leone, Guinea and Liberia as well as
Nigeria (ﬁgure 1a), and sporadic outbreaks have been
observed in neighbouring countries [13]. Its causal
agent LASV is an enveloped, bisegmented single-
stranded RNA virus (ﬁgure 1b) belonging to the large
arenavirus family. While no accurate numbers for mor-
bidity and fatality are available [17], it is believed that
thousands of people die from the disease each year
[13]. Despite the high rates of exposure in endemic
regions and potential fatality, notably between 50 per
cent and 90 per cent of West Africans infected show
few to no symptoms of disease [13], suggesting that
genetic factors of resistance may exist in the population.
While LF was not described until 1969, it is believed
tobemucholder[18].Sequencingstudiesofclinicaliso-
lates suggest that the virus originated in Nigeria, as most
of the viral diversity can be found in this country [19]
(ﬁgure 1c). Its natural reservoir Mastomys natalensis is
probably the most common rodent to tropical Africa
and rodent populations persistently infected with the
virus have reached countries throughout West Africa
[17]. They are commonly found near human settle-
ments in rural areas, and are eaten as an important
source of protein in some regions [20]. Before urbaniz-
ation and domestication of plants and animals, ancient
West Africans’ living and subsistence patterns would
probably have created greater risk of disease than in
most modern populations [21]. The likely antiquity of
the disease and continual exposure to the rodent reser-
voir over generations are characteristics that make
LASVagoodcandidateforselectivepressure.Moreover,
while today the case fatality is approximately 5 per cent
in the general population, the fatality is much greater in
pregnant women with foetal mortality nearly 100 per
cent [22], creating a strong selective pressure acting on
each generation. These ﬁndings—coupled with the
high rates of observed disease resistance in West
Africa, signiﬁcant mortality and disability in affected
individuals and sharing of a-DG as an entry receptor
amongst arenaviruses [23]—suggest that LASV and
LASV-like virusesserve asa likelysourceofstrong selec-
tive pressure, driving genetic variants conferring disease
resistance to high prevalence.
3. GENES IMPLICATED IN LASSA FEVER ARE
UNDER POSITIVE SELECTION IN WEST AFRICA
Given the potential impact of a disease as severe as LF
on human genome evolution, we decided to investigate
genes involved in LF pathogenicity that show evidence
of recent positive selection. Using the HapMap II
dataset, we scanned the human genome using the
long-range haplotype method iHS [9] and found evi-
dence for positive selection at the LARGE locus on
chromosome 22 (ﬁgure 2a) and IL21 locus on
chromosome four (ﬁgure 2b) in YRI. The LARGE
gene has previously been identiﬁed using other long-
range haplotype methods [10] and we found that the
signal is consistently found as one of the top-scoring
genes using a variety of selection methods and datasets
(data not shown).
Both LARGE and IL21 have a strong biologi-
cal association with LASV infection and disease.
LARGE is a glycosyltransferase that modiﬁes the
mucin domain of the LASV entry receptor a-DG.
It also interacts with the N-terminal domain of
a-DG and is required for the ability of LASV to
infect cells [12]. Therefore, it is possible that poly-
morphisms in LARGE found in the West African
population may confer direct protection against
LASV infection by decreasing the ability of the virus
to enter the cell.
IL21 is a member of the common g-chain family of
cytokines, which also includes IL2 and IL15 [24]. It is
crucial for effective clearance of chronic infection with
another member of the arenavirus family—lymphocytic
choriomeningitis virus (LCMV) [25–27]. This virus
shares a-DG receptor binding and much of its biology
with LASV and is a very commonly used pathogen in
immunological research [28]. Our data suggest that
polymorphisms in the region surrounding IL21 might
have been positively selected in West Africa, poten-
tially making individuals better able to cope with
LASV infection.
4. POSITIVE SELECTION WITHIN LARGE
LOCALIZES TO THE FIRST TWO INTRONS
Having identiﬁed a signal of selection at the LARGE
locus, we used CMS [11] to further narrow down
the signal. As true causal variants should display
most signatures of positive selection (long haplotype,
high-derived allele frequency and high population
differentiation), we expected this test to give us a
much better spatial resolution [11]. We used data
from the HapMap II project (approx. three million
SNPs) and from the initial phase of the 1000 G
(approx. 15 million SNPs) and compared the results
from both datasets.
We found that using either dataset, the signal of
positive selection localizes to the ﬁrst two introns
of LARGE. While the HapMap II analysis gave
approximately 15 high-scoring SNPs (ﬁgure 3a), the
1000 G analysis narrowed that down to around ﬁve
(ﬁgure 3b). Notably, all the ﬁve individual tests that
form the basis for CMS [11] were able to pick up sig-
nals within LARGE, but with a much lower resolution
(ﬁgure 3c). The fact that the selection signal is placed
mainly within introns suggests that the selected allele
of LARGE may be differentially regulated or
alternatively spliced.
To better visualize the extent of long-range associ-
ations of the ancestral and derived alleles, we created
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middle of the diagram displays the LARGE core haplo-
type. Going in either direction, it shows the breakdown
of proximal and distal linkage disequilibrium, by
branching off every time a new allele is present. The
thickness of the lines corresponds to the number of
samples with the indicated haplotype. As expected, the
derived allele of LARGE displayed clear long-range
associations to other neighbouring polymorphisms
(ﬁgure 3d), a signal suggestive of the recent emergence
of a young allele with an unusually high frequency in
West Africa (30% frequency in YRI, 0% in CEU and
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Figure 1. Lassa virus (LASV) is a highly divergent haemorrhagic fever-causing virus endemic to West Africa. (a) Map of Lassa
haemorrhagic fever (LF) endemic countries. (b) The LASV genome consists of two RNA segments that encode four proteins
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showed no such long-range associations, as is expected
for an old allele (ﬁgure 3e).
5. SELECTION AROUND IL21 LOCALIZES
TO A REGION CONTAINING THREE
DIFFERENT GENES
WeusedCMStolocalizethesignalofselectionobserved
near the IL21 locus. Using HapMap II and 1000G
analysis, we found that the signal narrowed down to a
300kb cluster on chromosome four containing
the genes ADAD1 and IL2 in addition to IL21
(ﬁgure 4a,b). Similar to that observed for LARGE,d a t a
from HapMap II or 1000G gave comparable results,
with 1000G having fewer high-scoring SNPs. Again,
CMS had much better power at localizing SNPs under
selection than any of the ﬁve individual tests (ﬁgure 4c).
Asexpected,thederivedalleleofIL21(59%frequencyin
YRI, 25% in CEU and 4% in CHB þ JPT), unlike its
ancestral counterpart, displayed long-range associa-
tions with nearby alleles when visualized in haplotype
bifurcation diagrams (ﬁgure 4d,e).
The top-scoring SNPs by CMS fall outside any of
the three genes’ ORFs, suggesting that selection may
have targeted variants that give rise to differential gene
expression—either at individual genes, or over the whole
cluster. Given the close spacing of the two common
g-chain cytokines IL2 and IL21, it is interesting to specu-
late that selection may have targeted regulatory regions
controlling the expression of both. Indeed, this potential
appears to exist within these loci, as certain SNPs in this
region have been implicated in an increased susceptibility
to the autoimmune disease type I diabetes [30].
6. LARGE AND IL21 SHOW DIFFERENT ANCIENT
PATTERNS OF EVOLUTION
Having identiﬁed signatures of recent positive natural
selection in the genomic regions containing LARGE
and IL21, we turned our attention to look for evidence
of ancient natural selection within the ORFs of these
two genes. CMS and haplotype-based methods allow
for the detection of recent and ongoing selection in the
human genome (within the last approx. 30000 years)
[3]. In contrast, methods to detect selection based on
multiple species comparisons such as non-synonymous
to synonymous (DN/DS) can elucidate evidence of natu-
ral selection as far back as the human split from other
apes millions of years ago [3]. We codon-aligned the
ORFs of the genes from at least 10 mammals and per-
formed a DN/DS analysis across the entire coding
sequence. At individual sites, an excess of DN over DS
is suggestive of positive selection, whereas a larger
number of DS over DN is suggestive of purifying selec-
tion. Using the random effects likelihood and ﬁxed
effects likelihood tests incorporated in the HYPHY pack-
age on the Datamonkey website [31], we found that the
LARGEgenehasbeenunder verystrongpurifyingselec-
tioninmammals(ﬁgure 5a)and the gene is100percent
identical in humans and chimpanzees (data not shown).
In contrast, IL21 appears to have been under moderate
positive selection in these species (ﬁgure 5b).
Next, we performed McDonald–Kreitman tests on
the ORFs of LARGE and IL21 to compare the level of
genetic variation within human populations (polymor-
phisms) with that of genetic variation between species
(divergence). For the purpose of minimizing the
number of multiple mutations at individual sites, we lim-
ited our comparison to humans and macaques—two
closely related species. However, we obtained very simi-
lar results when we compared humans with mice or rats
(data not shown).
For LARGE, the ratio of non-synonymous to
synonymous changes between species was signiﬁcantly
lower than the ratio of non-synonymous to synon-
ymous polymorphisms (ﬁgure 5c; 0.02 versus 0.58;
neutrality index: 23.92; p , 0.0001). This is vastly
different from the 1 : 1 ratio (neutrality index: 1)
expected under neutral conditions [32] and is unlike
that observed for the genome as a whole (ﬁgure 5e).
The very low proportion of non-synonymous substi-
tutions between species suggests that the gene has
been under strong purifying selection within the mam-
malian lineage. On the other hand, we identiﬁed an
unusually high proportion of polymorphisms in the
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other polymorphism datasets in the Single Nucleotide
Polymorphism Database (dbSNP), we found that the
gene had substantially more polymorphisms in human
populations than in rats, mice and chimpanzees
(ﬁgure 5f,g)—even when corrected for the larger
number of described human SNPs (ﬁgure 5f ). While
we found a signiﬁcant number of both synonymous and
non-synonymous SNPs in human LARGE,w eo b s e r v e d
only synonymous SNPs in mice and no SNPs at all in
chimpanzees and rats. This, combined with our sliding-
window analysis (ﬁgure 5a), suggests that whereas
LARGE has been under strong purifying selection in the
mammalian lineage, it may be more recently under
continuous diversifying selection in humans.
For IL21,thescenarioistheoppositeofthatobserved
forLARGE. For this gene, the ratioof non-synonymous
to synonymous changes between species was signiﬁ-
cantly greater than the ratio of non-synonymous to
synonymouspolymorphisms(ﬁgure 5d;7versus0;neu-
trality index: 0.00; p-value: 0.015). This is different
from the ratio expected under neutral conditions and
is also unlike the genome-wide observation (ﬁgure 5e).
Rather, this suggests that IL21 has undergone positive
selection in the mammalian lineage, whereas its ORF
appears ﬁxed in the human population.
7. HYPOTHESES FOR HOW VARIANTS
OF LARGE AND IL21 MAY CONFER
SELECTIVE ADVANTAGES
The molecular mechanisms behind positive selection
can target multiple biological pathways (table 1).
SNPs can lead to either non-synonymous, synonymous
LARGE
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Phil. Trans. R. Soc. B (2012)or non-coding changes that may alter protein function
or expression. Because most of the high-scoring SNPs
in LARGE and IL21 fall outside the ORFs, positively
selected variants of these genes may lead to regulatory
changes such as differential gene expression. Such a
change can result in a global change in gene expression
leading to a decreased or increased expression of the
genes. Alternatively, the changes in gene expression
may only affect particular cellular subsets or tissues.
For example, because dendritic cells express high
levels of a-DG and appear to be direct targets of
LASV infection [35], a difference in gene expression
of LARGE in these cells may lead to under or over gly-
cosylation of a-DG, interfering with LASV infectivity
[28]. The most attractive hypothesis involves SNPs
leading to decreased expression of LARGE and
therefore a reduced susceptibility to LASV infection
via a direct action on a-DG [12]. However, it has also
been shown that LASV itself downregulates LARGE/
a-DG—probably in order to bud off from infected
cells [36]. Another possible scenario would therefore
involve SNPs resulting in an increased expression of
LARGE and the inability of the virus to leave infected
cells. Given the localization of the signal to within the
ﬁrst two introns of LARGE, positive selection may also
have given rise to alternative splice variants of this
gene interfering with its function.
No non-synonymous changes have been observed in
the ORF of IL21, and our selection peak near this gene
lies together with IL2 and ADAD1. The most likely
scenario is therefore that SNPs under positive selection
may have targeted regulatoryelements causing a change
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diagrams were created for the SNP with the highest value of iHS in the CMS top-scoring SNPs. The proposed ancestral
(most abundant) haplotype on which the allele arose is shown in dark grey, whereas branch points are shown in light grey.
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tive role of IL21 in LF would probably be more
systemic and not speciﬁc to a single pathogen. Because
this cytokine has been shown to be involved in the clear-
ance of the arenavirus LCMV [25–27], it is possible
that certain SNPs leading to increased expression of
IL21 would have a protective role in LF progression.
This could ultimately results in enhanced immunity
against LASV and improved ability of the immune
system to cope with the infection. However, as with
LARGE the picture may be more complicated. It is cur-
rently unknown what causes LF to progress from severe
to fatal disease, but a likely explanation is that the
human immune system ’overreacts’, generating hyper-
active JAK/STAT and NF-kB signalling pathways.
The resulting ‘cytokine storm’ may ultimately be the
reason for a fatal outcome [37]. Decreased expression
of IL21, and potentially the closely linked IL2,
may therefore have protective effects by halting the
progression of LF from severe to fatal disease.
8. FUTURE DIRECTIONS
With ever-increasing numbers of large-scale datasets
and powerful computational methods to detect signals
of natural selection, the pursuit of evolutionary adap-
tations in humans has moved from testing of speciﬁc
observations such as sickle cell and malaria resistance
to a hypothesis-generating process. Now with many
candidates to pursue and better tools to pinpoint indi-
vidual SNPs under selection, the step from hypothesis
generating to hypothesis testing is as opportune as
ever. We have identiﬁed two genes biologically linked
to LF pathogenesis that make several testable predic-
tions, and we have initiated collaborations across
West Africa in order to test them. In particular, we
would expect to ﬁnd extreme correlations between
the absence or presence of protective alleles when
comparing the genotypes of LF patients and unrelated
controls. Given that a particular variant might confer
protection from LF, one would expect the frequency
of this allele to be absent or much lower in LF patients
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Figure 5. The open reading frames (ORFs) of LARGE and IL21 show evidence of purifying and positive selection. (a,b)
The ORFs from mammalian LARGE and IL21 were codon-aligned and the ratio of non-synonymous (DN) to synonymous
(DS) mutations were counted and the ratio between the two calculated. A log Bayes factor providing statistical support for
DN . DS at individual sites was calculated using the random effects likelihood test implemented at the Datamonkey website
[31]. Cutoff values for positive, neutral and purifying (negative) selection are marked on the diagrams in blue, green and red,
respectively. (c–e) McDonald–Kreitman tests comparing the amount of polymorphisms in LARGE and IL21 to that of the
divergence in these genes between humans and macaques [32,33]. (e) Results were compared with the genome-wide values
calculated from Bustamante et al. [34] (note that this comparison was between humans and chimpanzees). A neutrality
index was calculated as (PN/PS)/(DN/DS). p-Values were calculated using a two-sided chi-squared test. Values below 0.05
were considered statistically signiﬁcant. (f,g) The ORF of LARGE in humans has an unusually large number of SNPs com-
pared with other species. (f ) The numbers of synonymous and non-synonymous polymorphisms in the ORF of LARGE
from human, chimpanzee, mouse and rat were retrieved from dbSNP and normalized to the total number of SNPs found
in the LARGE locus from the respective species. (g) The fraction of SNPs found in the LARGE locus normalized to the
total number of SNPs from the individual species.
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ing this with serological assays to look for the presence
of previous exposure to LASV should help us get a
much clearer picture of the complex biology of this
devastating disease.
Comparing results found in the YRI of West Africa to
other more closely related African populations, but
experiencing different selective pressures, should also
prove productive. Indeed, phase III of the HapMap
generated genome-wide data for two East African popu-
lations, the Misai and Luo of Kenya, showing that
those African populations outside LF endemic areas do
not carry the selected haplotype of LARGE,w h e r e a s
the West African population YRI does. Similarly, the
frequencyof the selected haplotype of IL21 is signiﬁcan-
tly higher in YRI than in these other two populations.
However, more extensive surveys are required in order
to ﬁrmly establish this and we are setting out to examine
other West African populations where LF is and is not
endemic to further investigate the presence or absence
of selected haplotypes of LARGE and IL21.
Finally, for both LARGE and IL21 our studies
suggest that the most likely target of selection has
been differential gene regulation. This needs to be
conﬁrmed through extensive experimental studies,
such as qPCR proﬁles for LF patients and controls
combined with reporter assays and biochemical
tests in vitro. Combined, agnostic computational
methods such as CMS and rigorous reductionist
hypothesis testing in the laboratory should enable us
to take the ever-increasing list of natural selection can-
didates to validated examples of evolution in the
human species.
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